Altria Stock Price Falls 10% on Report FDA Will Ban Juul Products Markets Insider The FDA Just Approved Juul's E Cigarettes. Does That Make Altria Stock a Buy Here? After two costly vaping acquisitions (JUUL & NJOY), Altria shares are down 3% following the first ever authorization of non tobacco, non menthol flavored vapes. This once again raises questions around management's capital allocation in Altria Stock Sinks Amid Reports of Juul Ban Altria Faces Juul Antitrust Trials As Valuation Discount Draws Attention